News Release

<< Back

Sunesis to Present at Upcoming Investor Conferences

06/03/10

SOUTH SAN FRANCISCO, CA, Jun 03, 2010 (MARKETWIRE via COMTEX News Network) -- Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS), a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers, today announced that Daniel Swisher, Chief Executive Officer of Sunesis, will present at three upcoming conferences:

--  9th Annual Needham Healthcare Conference
     Wednesday, June 9 at 10:40
    a.m. EDT
     New York Palace Hotel, New York City


--  Jefferies 2010 Global Life Sciences Conference
     Thursday, June 10 at
    8:00 a.m. EDT
     Grand Hyatt, New York City


--  ThinkEquity Mid Year Check-Up on Healthcare
     Wednesday, June 16 at
    11:30 a.m. EDT
     The Princeton Club, New York City



Alive webcast of the Jefferies presentation on June 10th will be available on the Sunesis website at http://ir.sunesis.com. A replay of that webcast will be archived on the "Calendar of Events" page in the Investors and Media section of the Sunesis website for two weeks following the presentation.

About Sunesis Pharmaceuticals

Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. Sunesis has built a highly experienced cancer drug development organization committed to advancing its lead product candidate, voreloxin, in multiple indications to improve the lives of people with cancer. For additional information on Sunesis, please visit http://www.sunesis.com.

SUNESIS and the logo are trademarks of Sunesis Pharmaceuticals, Inc.

Investor and Media Inquiries:
Andrea Rabney
Argot Partners
212-600-1902

Eric Bjerkholt
Sunesis Pharmaceuticals Inc.
650-266-3717


SOURCE: Sunesis Pharmaceuticals, Inc.


Copyright 2010 Marketwire, Inc., All rights reserved.

News Provided by COMTEX